← Eichor
Condition: Trophoblast Cell Surface Antigen 2 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Trophoblast Cell Surface Antigen 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161532ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
NA · 1 location(s) · Deling Li · NCT07177482A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in
Phase 3 · 267 location(s) · Merck Sharp & Dohme LLC · NCT06841354Sacituzumab Govitecan in Recurrent Glioblastoma
Phase 2 · 3 location(s) · The University of Texas Health Science Center at San Antonio · NCT04559230Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/Phase 3 · 1 location(s) · RenJi Hospital · NCT06851663A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · 261 location(s) · Merck Sharp & Dohme LLC · NCT06952504DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Phase 2 · 37 location(s) · DualityBio Inc. · NCT06953089Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NA · 1 location(s) · RenJi Hospital · NCT07026110A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · 155 location(s) · Merck Sharp & Dohme LLC · NCT07216703A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06696326Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.